Skip to main content
. 2014 Dec 2;112(1):52–60. doi: 10.1038/bjc.2014.563

Figure 4.

Figure 4

Measurment of responses with 18FDG PET/CT imaging. (A) Example images of 18FDG PET/CT scan obtained from the same patient before (PET1) and after treatment (PET3). A change in the metabolic activity of the tumour between baseline and end of the treatment is clearly observed. (B) Tumour SUVmax values by the 18FDG PET/CT scan. The trend of the tumour metabolic activity during treatment for each patient. A significant reduction in SUVmax has been quantified in all thirteen patients from baseline to the definitive surgery (P-value: between PET1 and PET2 (P=0.015), between PET2 and PET3, (P=0.006) and between PET1 and PET3 (P=0.0002)).